Biogen Idec Investors

Biogen Idec is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.

Technology: NeuroPharmacology
Headquarters: Weston, Massachusetts, United States
Acquisitions Number: 9
Funding Status: IPO
Investment Stage: Early Stage Venture, Late Stage Venture
Founded Date: 1978
Number Of Exists: 15
Estimated Revenue: $1B to $10B
Employee Number: 5001-10000
Industry: Biotechnology, Health Care, Neuroscience, Therapeutics
Investor Type: Venture Capital